<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A simple, sensitive enzyme linked fluorescence immunoassay has been developed to detect IgM antibodies against Chlamydia trachomatis </plain></SENT>
<SENT sid="1" pm="."><plain>Reticulate bodies and elementary bodies from C trachomatis L2/434 Bu strain were isolated and used as antigens in the assay </plain></SENT>
<SENT sid="2" pm="."><plain>Of 113 serum samples obtained from infants with <z:hpo ids='HP_0002090'>pneumonia</z:hpo>, 27 (23.9%) had IgM antibodies to C trachomatis L2 reticulate bodies and nine (8.0%) had IgM antibodies to C trachomatis L2 elementary bodies (titre greater than or equal to 1/500) </plain></SENT>
<SENT sid="3" pm="."><plain>Specific IgM antibodies were not detected in 20 control serum samples obtained from healthy adults and children </plain></SENT>
<SENT sid="4" pm="."><plain>The possible use of enzyme linked fluorescence assay to determine IgM antibodies in the serodiagnosis of C trachomatis <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is discussed </plain></SENT>
</text></document>